Your browser doesn't support javascript.
Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?
Bilia, Silvia; Giannini, Daiana; Rizzelli, Grazia Maria Luisa; Tavoni, Antonio.
  • Bilia S; Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Giannini D; Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Rizzelli GML; Emergency Department, Nuovo Santa Chiara Hospital, U.O. Medicina d'Urgenza e Pronto Soccorso, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Tavoni A; Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. a.tavoni@int.med.unipi.it.
Clin Exp Rheumatol ; 38(3): 579, 2020.
Article in English | MEDLINE | ID: covidwho-404149
Search on Google
Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Still's Disease, Adult-Onset / Coronavirus Infections / Antirheumatic Agents / Interleukin 1 Receptor Antagonist Protein Limits: Adult / Humans Language: English Journal: Clin Exp Rheumatol Year: 2020 Document Type: Article Affiliation country: Italy

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Still's Disease, Adult-Onset / Coronavirus Infections / Antirheumatic Agents / Interleukin 1 Receptor Antagonist Protein Limits: Adult / Humans Language: English Journal: Clin Exp Rheumatol Year: 2020 Document Type: Article Affiliation country: Italy